Patents by Inventor Christopher Arendt

Christopher Arendt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY DRUG CONJUGATES
    Publication number: 20230399356
    Abstract: The present disclosure provides antibody drug conjugates comprising STING modulators. Also provided are compositions comprising the antibody drug conjugates. The compounds and compositions are useful for stimulating an immune response in a subject in need thereof.
    Type: Application
    Filed: June 16, 2023
    Publication date: December 14, 2023
    Inventors: He XU, Hong Myung LEE, Christopher ARENDT
  • Antibody drug conjugates
    Patent number: 11725024
    Abstract: The present disclosure provides antibody drug conjugates comprising STING modulators. Also provided are compositions comprising the antibody drug conjugates. The compounds and compositions are useful for stimulating an immune response in a subject in need thereof.
    Type: Grant
    Filed: April 27, 2022
    Date of Patent: August 15, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: He Xu, Hong Myung Lee, Christopher Arendt
  • ANTIBODY DRUG CONJUGATES
    Publication number: 20220249536
    Abstract: The present disclosure provides antibody drug conjugates comprising STING modulators. Also provided are compositions comprising the antibody drug conjugates. The compounds and compositions are useful for stimulating an immune response in a subject in need thereof.
    Type: Application
    Filed: April 27, 2022
    Publication date: August 11, 2022
    Inventors: He XU, Hong Myung LEE, Christopher ARENDT
  • ANTIBODY DRUG CONJUGATES
    Publication number: 20220168330
    Abstract: The present disclosure provides antibody drug conjugates comprising STING modulators. Also provided are compositions comprising the antibody drug conjugates. The compounds and compositions are useful for stimulating an immune response in a subject in need thereof.
    Type: Application
    Filed: November 9, 2021
    Publication date: June 2, 2022
    Inventors: He XU, Hong Myung LEE, Christopher ARENDT
  • COMPOSITIONS AND METHODS FOR TREATING ALLERGIC CONDITIONS
    Publication number: 20160030459
    Abstract: Compositions and methods are provided herein for treatment of allergic conditions, by administration of an adjuvant composition, with or without allergen.
    Type: Application
    Filed: January 20, 2015
    Publication date: February 4, 2016
    Inventors: Steven G. Reed, Christopher H. Clegg, Christopher Arendt, Alexandra Kropotova, Kurt Stoeckli
  • AZACARBOLINE DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME
    Publication number: 20110178053
    Abstract: The invention relates to novel azacarbonlines having formula (I), wherein: R3, R4 represent independently H; hal; CF3; substituted oxy, optionally substituted alkoxy; optionally substituted amino; substituted carbonyl; optionally substituted carboxyl; optionally substituted amide; sulphur, such as optionally substituted sulphones, sulphoxides or sulphides; linear, branched or cyclic C1-C10 alkyl optionally comprising an optionally substituted heteroatom; optionally substituted linear, branched or cyclic C2-C7 alkenyl; optionally substituted linear or branched C2-C6 alkynyl; optionally substituted aryl or heteroaryl; of which may be optionally substituted; in the form of a base or an acid addition salt. The invention also relates to the use of same in therapeutics for the treatment of cancer and to synthesis methods.
    Type: Application
    Filed: June 11, 2009
    Publication date: July 21, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Christopher Arendt, Didier Babin, Olivier Bedel, Thierry Gouyon, Mikhail Levit, Ronghua Li, Serge Mignani, Neil Moorcroft, David Papin